FDA Approves TB Pill That Cures More Hard-To-Treat Patients

This post was originally published on this site

TRENTON, N.J. (AP) — U.S. regulators Wednesday approved a new tuberculosis medicine that shortens and improves treatment for the hardest-to-treat cases, a worsening problem in many poor countries. It’s the first TB drug from a nonprofit group, the TB …

Click here to read full article